Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator

Eur J Med Chem. 2012 May:51:17-34. doi: 10.1016/j.ejmech.2012.02.021. Epub 2012 Feb 20.

Abstract

Estrogens are a group of steroids that exert important effects on reproductive and many non-reproductive tissues. Selective estrogen receptor modulators (SERM) are a class of therapeutic agents widely prescribed for the treatment and prevention of breast cancer, osteoporosis, and postmenopausal symptoms. Raloxifene, an example of oral SERM is prescribed primarily for the treatment and prevention of postmenopausal disorders in woman. The current review provides an outline of practical methodologies used to access benzothiophenyl scaffolds of raloxifene and relevant structural analogs. The contents are discussed in five sections: (a) synthesis of raloxifene, (b) organometallic analogs, (c) radiolabelled analogs, (d) constrained raloxifene analogs, and (e) other oxygen, sulfur, and nitrogen based raloxifene analogs. In addition to the synthesis, biological activity of a few synthetic analogs has been discussed.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Chemistry Techniques, Synthetic / methods*
  • Humans
  • Isotope Labeling
  • Organometallic Compounds / chemistry
  • Raloxifene Hydrochloride / analogs & derivatives
  • Raloxifene Hydrochloride / chemical synthesis*
  • Raloxifene Hydrochloride / chemistry
  • Receptors, Estrogen / metabolism*
  • Selective Estrogen Receptor Modulators / chemical synthesis*
  • Selective Estrogen Receptor Modulators / chemistry

Substances

  • Organometallic Compounds
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride